Health Blog
Feline infectious peritonitis (FIP) has long been a devastating diagnosis for cat owners, with no effective treatments available. However, a new compounded formulation of the antiviral drug GS-441524 is now available by veterinary prescription in the United States and Canada, offering hope for cats battling this once-fatal disease. Compounding Pharmacy, in collaboration with the Bova Group, announced on May 30, 2024, that it would begin offering a compounded oral formulation of GS-441524 for the treatment of FIP starting June 1st. This development marks a significant milestone in the fight against FIP, as it brings a potentially life-saving treatment into the hands of veterinarians and their feline patients. The crucial role of veterinarians in this new treatment protocol cannot be overstated. While cat owners may have previously sought out unapproved, black-market versions of GS-441524, the availability of a legally compounded formulation allows veterinarians to take the lead in diagnosing, prescribing, and monitoring FIP treatment. Veterinarians play a vital role in several key aspects of FIP treatment with compounded GS-441524:
Health Blog
Comments are closed.
|
Location |
|